Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Arrowhead Pharmaceuticals, Inc. company logo
Arrowhead Pharmaceuticals, Inc. logo

Arrowhead Pharmaceuticals, Inc. (ARWR)

Summary

As of today, ARWR price is $74.01, up +1.13% in the most recent trading session on
ARWR price is currently -97.47% below its historical high of $2,925.00 set on
ARWR current market cap is $10B, up +363.37% over the past 365 days
ARWR PE ratio is unknown
ARWR current annual revenue is $829.45M, up +23258.15% year-over-year
The next earnings release for ARWR is on

Profile

Company profile for Arrowhead Pharmaceuticals, Inc. (ARWR)
MetricValue
Full NameArrowhead Pharmaceuticals, Inc.
TickerNASDAQ: ARWR
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websitearrowheadpharma.com
Employees609

Key Metrics

Arrowhead Pharmaceuticals, Inc. Key Details
MetricDateValue
Price$74.01
Price, 1D Change+1.13%
Market Cap$10B
-
PE Ratio-
Beta1.70
Revenue$829M
Revenue, 1Y Change+23,258.15%
EPS-$0.01
EPS, 1Y Change+99.76%

Chart

SUGGESTED SERIES
Arrowhead Pharmaceuticals, Inc. chart

Events

Arrowhead Pharmaceuticals, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last Split1:10
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

ARWR Estimates
MetricDateValue
EPS-$0.01
EPS EstimateN/A-$3.00
EPS Est. ChangeN/A-24,513.93%
Revenue$829.45M
Revenue EstimateN/A$456.40M
Revenue Est. ChangeN/A-44.98%
Current Price$74.01
Price Target-$91.50
Price Tgt. Change-+23.64%

🔒 Log In To Unlock Full Data

EPS

ARWR EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$4.53-$5.00-10.53%
-$0.03-$0.01+63.69%
-$3.00N/A-24,513.93%
-$4.59N/A-37,547.54%
ARWR EPS reported versus estimate values chart

Revenue

ARWR revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$61.60M$3.55M-94.24%
$757.44M$829.45M+9.51%
$456.40MN/A-44.98%
$336.74MN/A-59.40%
ARWR revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

ARWR Performance
MetricDateValue
Price, 1Y+354.30%
Price, 3Y+104.04%
Market Cap, 1Y+363.37%
Market Cap, 3Y+168.85%
Revenue, 1Y+23,258.15%
Revenue, 3Y+241.01%
EPS, 1Y+99.76%
EPS, 3Y+99.27%

🔒 Log In To Unlock Full Data

Technicals

ARWR Technical Indicators
MetricDateValue
Current Price$74.01
SMA 200$52.21
SMA 200 vs Price-29.45%
SMA 50$67.00
SMA 50 vs Price-9.46%
Beta1.70
ATR$3.97
14-Day RSI50.20
10-Day Volatility68.14%
1-Year Volatility65.42%

Dividends

ARWR Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
$0.00
0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

ARWR Income & Profitability
MetricDateValue
Revenue$829.45M
EPS-$0.01
Gross Profit$805.52M
Gross Margin97.12%
Operating Profit$98.35M
Operating Margin11.86%
Net Income$30.11M
Net Margin3.63%
EBITDA$122.27M

🔒 Log In To Unlock Full Data

Financial Health

ARWR Financial Health
MetricDateValue
Debt To Equity1.57
4.86
4.86
-
2
6.45

Valuations

ARWR Valuations
MetricDateValue
PE Ratio-
16.76
16.98
-50.95
N/A-

Balance Sheet

ARWR Balance Sheet
MetricDateValue
Book Value$466.05M
$919.37M
$1.45B
$950.64M
$947.02M
$195.49M
Total Debt$733.68M
$47.29M
$17.67M

Expenses

ARWR Expenses
MetricDateValue
$831.08M
$707.17M
$23.93M
$0.00
$23.93M
$0.00
$21.42M

Cash Flow

ARWR Cash Flow
MetricDateValue
$179.55M
-$129.29M
$74.01M
Capex$22.67M
$156.89M

Recent analyst updates

ARWR Recent analyst updates
MetricDateValue
Bernstein→
RBC Capital→
JP Morgan
Morgan Stanley→
HC Wainwright & Co.→
HC Wainwright & Co.→
B. Riley Securities→
HC Wainwright & Co.→
Piper Sandler→
Morgan Stanley→

Analyst sentiment

Sentiment over the past month
ARWR analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
ARWR institutional ownership distribution chart

Screeners with ARWR

FAQ

  • What is the ticker symbol for Arrowhead Pharmaceuticals, Inc.?

    The ticker symbol for Arrowhead Pharmaceuticals, Inc. is NASDAQ:ARWR

  • Does Arrowhead Pharmaceuticals, Inc. pay dividends?

    No, Arrowhead Pharmaceuticals, Inc. does not pay dividends

  • What sector is Arrowhead Pharmaceuticals, Inc. in?

    Arrowhead Pharmaceuticals, Inc. is in the Healthcare sector

  • What industry is Arrowhead Pharmaceuticals, Inc. in?

    Arrowhead Pharmaceuticals, Inc. is in the Biotechnology industry

  • What country is Arrowhead Pharmaceuticals, Inc. based in?

    Arrowhead Pharmaceuticals, Inc. is headquartered in United States

  • When did Arrowhead Pharmaceuticals, Inc. go public?

    Arrowhead Pharmaceuticals, Inc. initial public offering (IPO) was on December 16, 1993

  • Is Arrowhead Pharmaceuticals, Inc. in the S&P 500?

    No, Arrowhead Pharmaceuticals, Inc. is not included in the S&P 500 index

  • Is Arrowhead Pharmaceuticals, Inc. in the NASDAQ 100?

    No, Arrowhead Pharmaceuticals, Inc. is not included in the NASDAQ 100 index

  • Is Arrowhead Pharmaceuticals, Inc. in the Dow Jones?

    No, Arrowhead Pharmaceuticals, Inc. is not included in the Dow Jones index

  • When was Arrowhead Pharmaceuticals, Inc. last earnings report?

    Arrowhead Pharmaceuticals, Inc.'s most recent earnings report was on May 7, 2026

  • When does Arrowhead Pharmaceuticals, Inc. report earnings?

    The next expected earnings date for Arrowhead Pharmaceuticals, Inc. is August 6, 2026

Data Sources & References

  1. ARWR Official Website arrowheadpharma.com
  2. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/879407/000087940725000029/0000879407-25-000029-index.htm
  3. ARWR Profile on Yahoo Finance finance.yahoo.com/quote/ARWR
  4. ARWR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/arwr